Symposium Overview and Purpose
The Emerging Pathways With Therapeutic
Potential in Cancer symposium will focus
on emerging targets in cellular pathways, such
as proliferation and growth, angiogenesis, and
apoptosis in cancer therapy. Further, means
to harness the host immune system will also
be discussed. This multidisciplinary meeting
will provide in-depth coverage of cutting-edge
translational cancer research, highlighting the most
promising novel therapeutics. The symposium will
describe the mechanisms of action of novel agents
that are currently in clinical development as well
as the potential impact of these targeted agents
on treatment outcome over the next 5-10 years.
The program will consist of a mixture of didactic
lectures and moderated discussions. Leading
oncology experts will participate as faculty.
This presentation was selected by the American Society of Clinical Oncology® as an independent educational activity held in conjunction with an ASCO® meeting. This presentation is not sponsored or endorsed by ASCO.
Target Audience
This educational program is directed toward
medical oncologists interested in reviewing the
most recent clinical trial data on therapeutic
treatments in cancer. Surgical and radiation
oncologists and other health professionals
interested in the treatment of cancer are also
invited to attend.
CME Accreditation and Credit Designation
Physicians’ Education Resource is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource designates this educational activity for a maximum of 2 AMA
PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent
of their participation in the activity.
Learning Objectives
At the conclusion of this symposium, you should be able to:
